Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom.
Snakebite is a significant cause of death and disability in subsistent farming populations of sub-Saharan Africa.Antivenom is the most effective treatment of envenoming and is manufactured from IgG of venom-immunised horses/sheep but, because of complex fiscal reasons, there is a paucity of antivenom in sub-Saharan Africa.To address the plight of t